NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

AIDS Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . May 11th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Vaccine Week | Other Publications

Adenovirus - Report summarizes adenovirus study findings from National Institutes of Health

Antiretrovirals - New antiretrovirals findings from New York University published

Hepatitis C Virus - Research from Emory University, Emory Vaccine Center provides new data on hepatitis C virus

HIV/AIDS - New findings from American University in the area of HIV/AIDS described

HIV/AIDS - Recent findings in HIV/AIDS described by P. Ravanfar and colleagues

HIV/AIDS - Research from Novartis broadens understanding of HIV/AIDS

HIV/AIDS - Research on HIV/AIDS reported by scientists at Massachusetts General Hospital

HIV/AIDS - Studies from University of Toronto in the area of HIV/AIDS published

HIV/AIDS Co-Infection - University of Lausanne reports research in HIV/AIDS co-infection

Life Sciences - Study results from Harvard University, Medical Department in the area of life sciences published

Bacilligen, Inc. - Bacilligen, Inc. To Develop Influenza Vaccine

GAVI Alliance and Wyeth and PneumoADIP and Rwanda Ministry of Health - Rwanda Becomes First Developing Nation to Introduce Vaccine for World’s Leading Infectious Child Killer

HIV/AIDS Co-Infection - CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease

Malaria Vaccines - Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

NanoViricides, Inc. - NanoViricides, Inc. Says Flu-Cide Drug Designed to Destroy All Influenza a Viruses Including Swine and Bird Flu



Return to Top of Page

-----------------------
PR Login